We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Forendo

News List

Organon to Acquire Forendo Pharma AmericanPharmaceuticalReview
November 12, 2021
Organon and Forendo Pharma announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company...
FOR-6219 shows promise in Phase I endometriosis trial contractpharma
March 04, 2021
FOR-6219 was found to be safe and well tolerated by healthy pre- and postmenopausal women and did not induce systemic oestrogen deficiency-related side effects.
Novartis and Forendo enter into tissue hormone-focused licensing collaboration pharmaceutical-technology
December 16, 2019
Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis.
Forendo Pharma Initiates Endometriosis Study americanpharmaceuticalreview
July 11, 2018
Forendo Pharma has received clinical trial authorization (CTA) from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to commence a study for its lead program FOR-6219.